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ANNOUNCEMENT 
The annual meeting of the Society for Pediatric Dermatology will be held July 28-31, 1993 at 
Snowmass, Colorado. The meeting will immediately follow the 42nd annual Symposium on 
the Biology of Skin. Those wishing further information please write to: 
SPD-Snowmass 
Department of Dermatology B-153 
University of Colorado School of Medicine 
4200 East Ninth Avenue ' 
Denver, Colorado 80262 
